The latest news from the global pharmaceutical industry. Below you will find news and information to keep you up-to-date with what is happening in your industry. Coverage includes regulatory approvals, recall announcements, mergers and acquisitions, personnel news and appointments, new facility and facility expansion updates, collaborations and agreements, and financial updates.
NanoViricides has requested a pre-IND meeting with the US FDA, as it progresses its lead drug candidate towards human clinical trials.
read more
Daiichi Sankyo announced the FDA has extended the review period for the NDA of quizartinib currently under Priority Review for the treatment of adult ...
read more
Merrimack announced the Company is discontinuing development of MM-310, its antibody-directed nanotherapeutic for the treatment of solid tumors.
read more
The FDA approved Dovato, as a complete regimen for the treatment of HIV-1 infection in adults with no antiretroviral treatment history.
read more
Soligenix announced the Pediatric Committee of the European Medicines Agency (EMA) agreed to the Company's Pediatric Investigation Plan for SGX942 (...
read more
Biomica announced the initiation of pre-clinical studies for BMC-121 & BMC-127, two rationally-designed microbial consortia, in its therapeutic immuno...
read more
Wednesday, April 17, 2019
Circassia announced the FDA has approved DUAKLIR® PRESSAIR® for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD...
read more
Wednesday, April 17, 2019
NeoImmuneTech announced the FDA has granted ODD to Hyleukin-7TM, a T cell amplifier, in development for the treatment of Idiopathic CD4+ ...
read more
TB Alliance and Mylan announced a global collaboration to make the experimental drug pretomanid accessible for use in two investigational drug ...
read more
TAU BIO-LOGIC in collaboration with LifeArc has successfully humanized a monoclonal antibody (TBL-100) that targets C-terminally truncated tau (tauC3)...
read more
PPMD announced the Research Institute at Nationwide Children's Hospital have completed work under a grant exploring GALGT2 gene therapy technology as ...
read more
Start Codon has been founded and launched with funding from keystone investors including Cambridge Innovation Capital, Babraham Bioscience, Genentech,...
read more
OncoSec Medical announced a triple combination clinical trial of OncoSec's TAVO™, epacadostat, and KEYTRUDA® in patients with squamous cell carcinoma ...
read more
Wednesday, April 24, 2019
Belite Bio announced the FDA has approved its IND for LBS-008, a first-in-class oral therapy for the treatment of AMD and Stargardt disease.
read more
Ampio Pharmaceuticals has received comments from the FDA regarding their Special Protocol Assessment (SPA).
read more